Schonfeld Strategic Advisors’s Treace Medical Concepts TMCI Stock Holding History

Schonfeld Strategic Advisors’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$109K	Buy	+27,277	New	+$75K	﹤0.01%	2296
2026 Q1	–	Sell	-62,674	Closed	-$154K	–	2670
2025 Q4	$154K	Sell	62,674 -373	-0.6%	-$1.62K	﹤0.01%	1759
2025 Q3	$423K	Sell	63,047 -239,156	-79%	-$1.56M	﹤0.01%	1730
2025 Q2	$1.78M	Sell	302,203 -84,300	-22%	-$549K	0.01%	1044
2025 Q1	$3.24M	Buy	+386,503	New	+$3.47M	0.02%	710
2024 Q1	–	Sell	-12,930	Closed	-$165K	–	2408
2023 Q4	$165K	Buy	+12,930	New	+$131K	﹤0.01%	1564
2023 Q2	–	Sell	-21,300	Closed	-$537K	–	2493
2023 Q1	$537K	Buy	+21,300	New	+$500K	0.01%	1148

Other funds holding TMCI

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

CBU

CIBC Bancorp USA Chicago, Illinois $82.3B AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Schonfeld Strategic Advisors's TMCI Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in Treace Medical Concepts (TMCI) in Q2 2026: 27,277 shares worth $109K. The stake represents ﹤0.01% of the portfolio and ranks #2296 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in TMCI as recently as Q4 2025.

Schonfeld Strategic Advisors first reported a position in TMCI in Q1 2023 and has held it in 7 quarters since. The position peaked at $3.24M in Q1 2025. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

Schonfeld Strategic Advisors held 27,277 shares of Treace Medical Concepts worth $109K as of Q2 2026.
Treace Medical Concepts was a new Schonfeld Strategic Advisors position in Q2 2026.
Treace Medical Concepts made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #2296 holding.
Schonfeld Strategic Advisors first reported a position in Treace Medical Concepts in Q1 2023 and has held it in 7 quarters since.
Schonfeld Strategic Advisors's Treace Medical Concepts position peaked at $3.24M in Q1 2025.
116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.